SCHEMBL14792046

SCHEMBL14792046

C=C1OB(c2ccc3c(c2)c(C=O)nn3C2CCCCO2)OC1(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6508680 0.87 RET (0.32) —
SCHEMBL30124206 0.87 RET (0.32) —
SCHEMBL26925293 0.80 RET (0.32) —
SCHEMBL13558784 0.76 CYP4F2 (0.38) —
SCHEMBL22113278 0.75 RET (0.33) —
SCHEMBL19001412 0.74 RET (0.33) —
SCHEMBL16881008 0.74 RXRA (0.35) —
SCHEMBL16100177 0.74 CYP4F2 (0.40) —
SCHEMBL5809971 0.74 CYP4F2 (0.38) —
SCHEMBL16100304 0.74 CYP4F2 (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013040215-A1 INDAZOLE-3-CARBOXAMIDES AND THEIR USE AS WNT/B-CATENIN SIGNALING PATHWAY INHIBITORS SAMUMED, LLC (US) 2013-03-21 — — WO disclosed
Send feedback